This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Risk of Heart Failure-related Events in Patients Exposed to Medical Cannabis: A Longitudinal Cohort Study.
American journal of medicine open · 2026 · senior author
Opioid Initiation in Older Patients with Chronic Pain Who Received Authorized Cannabis Prescription.
Substance use & misuse · 2026 · senior author
Concomitant use of medical cannabis and drugs associated with risks of interaction in older patients: a longitudinal cohort study.
Age and ageing · 2025 · senior author
Latest funding
- $328,952
Assessing the protective effect of dutasteride on Parkinson's disease: a real-world study following preclinical assessment
CIHR · 2025 · Nominated PI
- $359,550
Comparative Safety of the Sodium Glucose Co-transporter-2 (SGLT-2) Inhibitors in Patients with Type 2 Diabetes
CIHR · 2017 · Co-investigator
8 publications.
Risk of Heart Failure-related Events in Patients Exposed to Medical Cannabis: A Longitudinal Cohort Study.
Dubois C, Eurich DT, Dyck JRB, Hyshka E, Hanlon JG, Zongo A
Opioid Initiation in Older Patients with Chronic Pain Who Received Authorized Cannabis Prescription.
Fontaine E, El-Mourad J, Dubois C, Eurich DT, Dyck JRB, Hanlon JG, Zongo A
Concomitant use of medical cannabis and drugs associated with risks of interaction in older patients: a longitudinal cohort study.
Bérété ZC, Sebgo AA, Eurich DT, Dubois C, Dyck JR, Hanlon JG, Zongo A
Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study.
Dubois C, Lunghi C, Eurich DT, Dyck JRB, Hyshka E, Hanlon JG, Zongo A
Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study.
Zongo A, Lee C, Dyck JRB, El-Mourad J, Hyshka E, Hanlon JG, Eurich DT
Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study.
Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, Gamble JM
Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study.
Zongo A, Lee C, Dyck JRB, El-Mourad J, Hyshka E, Hanlon JG, Eurich DT
Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada.
Eurich D, Lee C, Zongo A, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck J
Assessing the protective effect of dutasteride on Parkinson's disease: a real-world study following preclinical assessment
Principal investigators: Zongo, Arsene; Soulet, Denis
Keywords: 5-Alpha-Reductase Inhibitors; Cohort Study; Dutasteride; Effectiveness; Parkinson'S Disease; Real-World Data; Tamsulosin
Comparative Safety of the Sodium Glucose Co-transporter-2 (SGLT-2) Inhibitors in Patients with Type 2 Diabetes
Principal investigators: Gamble, John-Michael; Eurich, Dean
Keywords: Antidiabetic Medications; Database Analysis; Diabetes Mellitus; Drug Safety; Health Outcomes; Observational Study; Pharmacoepidemiology; Population Health
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- John-Michael Gamble and wajd Alkabbani: 19 shared papers
- Elaine Hyshka and Arsene Zongo: 4 shared papers
- Jason Dyck and Dean Eurich: 1 shared paper
- Jason Dyck and Elaine Hyshka: 1 shared paper
- Jason Dyck and Arsene Zongo: 1 shared paper
- Dean Eurich and Elaine Hyshka: 1 shared paper
- Dean Eurich and Arsene Zongo: 1 shared paper
- John-Michael Gamble and Arsene Zongo: 1 shared paper
- wajd Alkabbani and Arsene Zongo: 1 shared paper
- School of Pharmacy
- Medicine
- Cardiology
- Pediatrics
- Other
Co-authors at Université Laval, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.